Results 41 to 50 of about 90,654 (272)

Artificial Intelligence as the Next Visionary in Liquid Crystal Research

open access: yesAdvanced Functional Materials, EarlyView.
The functions of AI in the research laboratory are becoming increasingly sophisticated, allowing the entire process of hypothesis formulation, material design, synthesis, experimental design, and reiterative testing to be automated. In our work, we conceive how the incorporation of AI in the laboratory environment will transform the role and ...
Mert O. Astam   +2 more
wiley   +1 more source

The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue

open access: yesScientific Reports, 2021
To circumvent time-consuming clinical trials, testing whether existing drugs are effective inhibitors of SARS-CoV-2, has led to the discovery of Remdesivir.
Melissa Zimniak   +9 more
doaj   +1 more source

Fluoxetine increases astrocytic glucose uptake and glycolysis in corticosterone-induced depression through restricting GR-TXNIP-GLUT1 Pathway

open access: yesFrontiers in Pharmacology, 2022
Antidepressant fluoxetine can affect cerebral glucose metabolism in clinic, but the underlying molecular mechanism remains poorly understood. Here, we examined the effect of fluoxetine on brain regional glucose metabolism in a rat model of depression ...
Shu-Man Pan   +7 more
doaj   +1 more source

Serotonergic System‐Targeted Nucleic Acid Hydrogel Coordinates Excitability Restoration and Circuit Reconstruction for Spinal Cord Injury Therapy

open access: yesAdvanced Materials, EarlyView.
The study reports a DNA/RNA heteroduplex hydrogel (SeroPTEN‐CG) that undergoes DNase‐mediated hydrogel‐to‐nanogel transition for spinal cord injury therapy by targeting the serotonergic system, combining 5‐hydroxytryptamine (5‐HT)‐mediated excitability restoration to reactivate dormant interneurons with phosphatase and tensin homolog (PTEN)‐targeted ...
Chunlin Li   +19 more
wiley   +1 more source

The role of harms and burdens in clinical practice guidelines: Lessons learned from the American Psychological Association's guideline development

open access: yesClinical Psychology: Science and Practice, EarlyView., 2020
Abstract Growing evidence supports the efficacy of various psychosocial interventions yet provides very little information about the potential harms and burdens of treatment. Lacking such information makes it difficult to make truly informed decisions about treatment options.
Raquel W. Halfond   +2 more
wiley   +1 more source

Management of Widespread Pain and Fibromyalgia [PDF]

open access: yes, 2016
Peer reviewedPublisher ...
Basu, Neil   +2 more
core   +2 more sources

Repurposing of paroxetine and fluoxetine for their antibacterial effects against clinical Pseudomonas aeruginosa isolates in Egypt

open access: yesAIMS Microbiology
BackgroundDrug repositioning has emerged as a promising strategy for assessing its antimicrobial efficacy in treating infectious diseases.MethodsSeventy-five samples were collected and investigated for the presence of Pseudomonas aeruginosa.
Kholoud Baraka   +4 more
doaj   +1 more source

Transcriptomic evidence for immaturity induced by antidepressant fluoxetine in the hippocampus and prefrontal cortex

open access: yesNeuropsychopharmacology Reports, 2019
Aims The molecular and cellular mechanisms underlying the antidepressant effects of fluoxetine in the brain are not fully understood. Emerging evidence has led to the hypothesis that chronic fluoxetine treatment induces dematuration of certain types of ...
Hideo Hagihara   +2 more
doaj   +1 more source

Testing of analgesic effect of fluoxetine

open access: yesBiomolecules & Biomedicine, 2004
Fluoxetine is used in treatment of depression caused by a variety of different factors and from year to year new indications are being added, especially in conditions followed with strong bouts of pain.
Amra Begović   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy